CAUWENBERGH GEERT 4
4 · RXi Pharmaceuticals Corp · Filed Oct 2, 2017
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Purchase
Common stock, $0.0001 par value
2017-10-02$0.44/sh+2,700$1,188→ 135,283 total - Purchase
Common stock, $0.0001 par value
2017-10-02$0.46/sh+200$92→ 135,483 total - Purchase
Common stock, $0.0001 par value
2017-10-02$0.45/sh+7,100$3,195→ 142,583 total
Holdings
- 4,500(indirect: By Spouse)
Common stock, $0.0001 par value
- 450(indirect: By son)
Common stock, $0.0001 par value
Footnotes (1)
- [F1]Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shall not constitute an admission of beneficial ownership.